In Q2 fiscal 2026 (the quarter ended June 30, 2026), Willis Towers Watson Public's largest business segment was Health, Wealth and Career, with $1.29 billion or 53% of revenue, up 7.8% from a year earlier. Next: Risk and Broking (47%).
By product or service, Broking brought in 46%, Consulting brought in 36% and Outsourced Administration brought in 12% of revenue in Q2 fiscal 2022.
By region, Foreign Countries brought in 98% and Ireland brought in 2% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Risk and Broking (+11.2%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Health, Wealth and Career | $1.3B | $1.3B | $1.3B | $1.2B | 53% |
| Risk and Broking | $1.2B | $1.1B | $1.0B | $1.1B | 47% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Broking | – | – | – | – | 46% |
| Consulting | – | – | – | – | 36% |
| Outsourced Administration | – | – | – | – | 12% |
| Other | – | – | – | – | 6% |
In USD, fiscal quarters as reported; share = part of Q2 FY22 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Foreign Countries | $2.4B | $2.4B | $2.3B | $2.2B | 98% |
| Ireland | $42.0M | $39.0M | $33.0M | $37.0M | 2% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Health, Wealth and Career and Risk and Broking (as reported for Q2 fiscal 2026).
Health, Wealth and Career: $1.29 billion, or 53% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2022: Broking (46%), Consulting (36%), Outsourced Administration (12%) and Other (6%).
By region in Q2 fiscal 2026: Foreign Countries (98%) and Ireland (2%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Health, Wealth and Career | USD 1.29B | 52.5% |
| Risk and Broking | USD 1.17B | 47.5% |
| Corporatei | USD 6.00M |
Sum of items USD 2.46B; corporate items and eliminations USD 6.00M. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q1 FY22 | Q4 FY21 | Q3 FY21 | Q2 FY21 | Q1 FY21 | Q4 FY20 | Q3 FY20 | Q2 FY20 | Q1 FY20 | Q4 FY19 | Q3 FY19 | Q2 FY19 | Q1 FY19 | Q4 FY18 | Q3 FY18 | Q2 FY18 | Q1 FY18 | Q4 FY17 | Q3 FY17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health, Wealth and Career | 1.3B | 1.3B | 1.7B | 1.3B | 1.2B | 1.2B | 1.9B | 1.3B | 1.3B | 1.4B | 1.8B | 1.3B | 1.2B | 1.3B | 1.7B | 1.2B | 1.2B | 1.3B | – | 1.2B | 1.2B | 1.2B | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Risk and Broking | 1.2B | 1.1B | 1.3B | 1.0B | 1.1B | 1.0B | 1.1B | 943.0M | 982.0M | 981.0M | 1.1B | 858.0M | 903.0M | 907.0M | 956.0M | 767.0M | 854.0M | 894.0M | – | 787.0M | 887.0M | 925.0M | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Human Capital and Benefits | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 899.0M | – | – | – | – | 796.0M | 776.0M | 855.0M | – | 822.0M | 812.0M | 843.0M | 860.0M | 778.0M | 797.0M | 846.0M | – | 733.0M |
| Corporate Risk and Broking | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 883.0M | – | – | – | – | 649.0M | 695.0M | 721.0M | – | 651.0M | 690.0M | 728.0M | 816.0M | – | – | – | – | – |
| Investment Risk and Reinsurance | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 202.0M | – | – | – | – | 220.0M | 412.0M | 615.0M | – | 327.0M | 411.0M | 591.0M | 283.0M | 317.0M | 386.0M | 576.0M | – | 321.0M |
| Corporate | 6.0M | 9.0M | 9.0M | – | 13.0M | 11.0M | 17.0M | – | 8.0M | 7.0M | 12.0M | 10.0M | 23.0M | 35.0M | – | 8.0M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 622.0M | 674.0M | 740.0M | – | 600.0M |
| Benefits Delivery and Administration | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 734.0M | – | – | – | – | 226.0M | 211.0M | 234.0M | – | 181.0M | 128.0M | 138.0M | 392.0M | 127.0M | 121.0M | 124.0M | – | 181.0M |
| Corporate and other | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.0M | 9.0M | – | – | – | 6.0M | – | – | 7.0M | 9.0M | – | 8.0M | 7.0M | 12.0M | 21.0M | 4.0M | 5.0M | 4.0M | – | – |
| Reconciling items | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.0M | – | – | – | – | – | – | – | 15.0M | 32.0M | 24.0M | – | 17.0M |
| Divested Businesses | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.0M | 51.0M | – | – | – | – | – | – | – | – | – | – | – | – | – | – |